Malignant Tumors of the Liver and Intrahepatic Bile Ducts
It has been estimated that there are about 748,3000 cases of newly diagnosed liver cancer worldwide with a mortality of 695,900 cases each year. More than 80% of hepatocellular carcinoma (HCC) is discovered in sub-Saharan Africa or Asia, while the Western
- PDF / 88,078,154 Bytes
- 377 Pages / 595.35 x 807.87 pts Page_size
- 90 Downloads / 198 Views
Surgical Pathology of Hepatobiliary Tumors
123
Surgical Pathology of Hepatobiliary Tumors
Wen-Ming Cong Editor
Surgical Pathology of Hepatobiliary Tumors
Editor Wen-Ming Cong Department of Pathology Eastern Hepatobiliary Surgery Hospital Second Military Medical University Shanghai, China
The print edition is not for sale in China Mainland. Customers from China Mainland please order the print book from: People’s Medical Publishing House. ISBN 978-981-10-3535-7 ISBN 978-981-10-3536-4 (eBook) DOI 10.1007/978-981-10-3536-4 Library of Congress Control Number: 2017932888 © Springer Nature Singapore Pte Ltd. and People’s Medical Publishing House 2017 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer Nature Singapore Pte Ltd. The registered company address is: 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore
Foreword
China has a high incidence of hepatobiliary tumors at present and even in the forthcoming decades. With rapid development in the field of hepatic surgery, pathology should play a more supportive role in the improvement of clinical diagnosis and treatments. In order to greatly improve the long-term therapeutic effects of hepatocellular carcinoma (HCC), researchers and clinicians are making huge efforts of developing standardized individual clinic mode to diagnose and treat hepatic tumors, which would lead to more emphasis on the research and understanding of the pathobiological features of HCC. Now there is an increasing realization that exploration of clinic mode to treat HCC in the perspective of biological characterization is an optimal way to greatly improve the efficacy of early diagnosis and treatment, and the instructive function of HCC diagnosis and treatment standards on individualized treatment is lim
